Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound.

ABSTRACT:

Background

Focused transthoracic echocardiography (fTTE) has emerged as a critical diagnostic tool during the COVID-19 pandemic, allowing for efficient cardiac imaging while minimizing staff exposure. The utility of fTTE in predicting clinical outcomes in COVID-19 remains under investigation.

Methods

We conducted a retrospective study of 2,266 hospitalized patients at Rush University Medical Center with COVID-19 infection between March and November 2020 who received a fTTE. fTTE data were analyzed for association with primary adverse outcomes (60-day mortality) and with secondary adverse outcomes (need for renal replacement therapy, need for invasive ventilation, shock, and venous thromboembolism).

Results

Of the 427 hospitalized patients who had a fTTE performed (mea

SUBMITTER: Gomez JMD 

PROVIDER: S-EPMC8872842 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature